Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: Results of a prospective randomized study

Journal of the American College of Cardiology

Volumn 59, Issue 19, 2012, Pages 1681-1687

  Tello Montoliu, Antonio ^a   Tomasello, Salvatore D ^a   Ferreiro, José Luis ^a   Ueno, Masafumi ^a   Seecheran, Naveen ^a   Desai, Bhaloo ^a   Kodali, Murali ^a   Charlton, Ronald K ^a   Box, Lyndon C ^a   Zenni, Martin M ^a   Guzman, Luis A ^a   Bass, Theodore A ^a   Angiolillo, Dominick J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

percutaneous coronary intervention; platelet function; prasugrel

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; PRASUGREL; PROTON PUMP INHIBITOR; PURINERGIC P2Y12 RECEPTOR;

ACUTE CORONARY SYNDROME; ADULT; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; BLEEDING DISORDER; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIGHT TRANSMISSION AGGREGOMETRY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHARMACODYNAMICS; PLATELET REACTIVITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETHNIC GROUPS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PLATELET AGGREGATION; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; THIOPHENES; TIME FACTORS;

EID: 84860475435     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.12.039     Document Type: Article

References (14)

1. G.N. Levine, E.R. Bates, J.C. Blankenship et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 2550 2583
2. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. D.J. Angiolillo, J.J. Badimon, J.F. Saucedo A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing Anti-Platelet Therapy in Diabetes Mellitus (OPTIMUS)-3 trial Eur Heart J 32 2011 838 846
4. D.J. Angiolillo, J.F. Saucedo, R. Deraad Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (Switching Anti-Platelet) study J Am Coll Cardiol 56 2010 1017 1023
5. A. Kastrati, N. von Beckerath, A. Joost, G. Pogatsa-Murray, O. Gorchakova, A. Schomig Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy Circulation 110 2004 1916 1919
6. J.P. Collet, J. Silvain, A. Landivier Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload With Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term With Dual Antiplatelet Therapy (RELOAD) study Circulation 118 2008 1225 1233
7. G. Montalescot, G. Sideris, R. Cohen Prasugrel compared with high-dose clopidogrel in acute coronary syndrome The randomised, double-blind ACAPULCO study Thromb Haemost 103 2010 213 223
8. L. Wallentin, C. Varenhorst, S. James Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Eur Heart J 29 2008 21 30
9. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
10. L. Bonello, U.S. Tantry, R. Marcucci Working Group on High On-Treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
11. D.J. Angiolillo, M. Ueno, S. Goto Basic principles of platelet biology and clinical implications Circ J 74 2010 597 607
12. L. Bonello, L. Camoin-Jau, S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411
13. G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, A. Montinaro Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) randomized trial Eur Heart J 31 2010 1337 1343
14. L. Bonello, M. Pansieri, J. Mancini High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes J Am Coll Cardiol 58 2011 467 473